Evidera CEO and leadership

Jaime advances Evidera’s leadership in developing and applying novel techniques in modeling, health economics, comparative effectiveness, epidemiology, and outcomes research. Jaime trained at McGill University, where he practiced internal medicine and continues as adjunct Professor of Medicine, as well as of Epidemiology and Biostatistics. He established the graduate-level course in pharmacoeconomics, which he continues to direct, and also lends his teaching ability to other academic institutions such as Thomas Jefferson University School of Population Health and the Massachusetts College of Pharmacy and Health Sciences. Jaime recently led the Quality Assurance for Modeling Studies Task Force, jointly sponsored by ISPOR, Academy of Managed Care Pharmacy and the National Pharmaceutical Council. It produced a set of tools to help decision makers assess economic models. Previously, he led the ISPOR-SMDM Good Modeling Practices Task Force, endorsed by the Society for Medical Decision Making, to produce the new guidelines for good modeling practices. This has resulted in seven papers covering topics from the design, through the building and populating, to the validation of models. Recently, Jaime has been working on developing a new modeling technique, DICE, tailored to problems in Health Technology Assessment. He has helped the World Bank Institute and the InterAmerican Court for Human Rights address the growing problem of Supreme Courts overriding health care system decisions and ordering them to provide treatments that had been considered unwarranted.